MIRA
MIRA PHARMACEUTICALS, INC.
Key Financials
Total Assets
$11.1M
↑ 279.5%
Net Income
$-10442485
↓ 33.0%
Total Liabilities
$702068.00
↓ 2.9%
Cash & Equivalents
$6.3M
↑ 124.0%
EPS (Diluted)
$-1.35
↓ 164.7%
Shareholders' Equity
$10.4M
↑ 372.4%
Operating Cash Flow
$-4661669.00
↑ 16.2%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 4/1/2026 | View on SEC |
| 10-K | 3/31/2026 | View on SEC |
| 8-K | 3/23/2026 | View on SEC |
| 8-K | 3/3/2026 | View on SEC |
| 5 | 2/17/2026 | View on SEC |
| 8-K | 2/2/2026 | View on SEC |
| 8-K | 12/22/2025 | View on SEC |
| 8-K | 12/5/2025 | View on SEC |
| 424B5 | 12/5/2025 | View on SEC |
| 10-Q | 11/13/2025 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | MIRA |
| Company Name | MIRA PHARMACEUTICALS, INC. |
| CIK | 1904286 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| State of Incorporation | FL |
| Phone | 813-369-5150 |